Discover 2,532 paid clinical trials in Fairfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,532
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: San Francisco CA, Stanford CA, Los Angeles CA,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase2, Phase3, Recruiting
A Study of ZW251 in Participants With Advanced Solid Tumors
for
Hepatocellular Carcinoma,
Location: San Francisco CA, Santa Monica CA, San Antonio TX,
Sponsor: Zymeworks BC Inc.
Sex: All
Age: 18+
Code: NCT07164313
Phase1, Recruiting
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors, Advanced Breast Cancer
Location: San Francisco CA, Newport Beach CA, Seattle WA,
Sponsor: Ensem Therapeutics
Sex: All
Age: 18+
Code: NCT06993844
Phase1, Phase2, Recruiting
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
for
Prostate Cancer
Location: San Francisco CA, Madison WI, Ann Arbor MI, Durham NC
Sponsor: Duke University
Sex: Male
Age: 18+
Code: NCT07050433
Recruiting
A Study of ZL-1310 in Participants With Selected Solid Tumors
for
Solid Tumors
Location: San Francisco CA, Dallas TX, McAllen TX, Houston TX,
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06885281
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: San Francisco CA, Westwood, Los Angeles CA,
Sponsor: Fore Biotherapeutics
Sex: All
Age: 8+
Code: NCT05503797
Phase2, Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
for
Oncology, MEK Mutation, RAF Gene Mutation,
Location: San Francisco CA, Westwood, Los Angeles CA, Houston TX,
Sponsor: Nested Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06326411
Phase1, Recruiting
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
for
Prostate Adenocarcinoma
Location: San Francisco CA, Fresno CA, Portland OR, Milwaukee WI,
Sponsor: Alessa Therapeutics Inc.
Sex: Male
Age: 21+
Code: NCT06257693
Phase1, Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: San Francisco CA, Palo Alto CA, Santa Monica CA,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase1, Recruiting
ATEMPT 2.0: Adjuvant T-DM1 vs TH
for
Breast Cancer, HER2-positive Breast Cancer
Location: San Francisco CA, Houston TX, Chicago IL, Nashville TN,
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04893109
Phase2, Recruiting
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
for
Advanced Solid Tumors With KRAS G12C Mutations,
Location: San Francisco CA, La Jolla CA, West Valley City UT,
Sponsor: Frontier Medicines Corporation
Sex: All
Age: 18+
Code: NCT06244771
Phase1, Phase2, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: San Francisco CA, Santa Rosa CA, Stockton CA,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase2, Phase3, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: San Francisco CA, Palo Alto CA, Bakersfield CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase3, Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for
Urothelial Carcinoma
Location: San Francisco CA, Templeton CA, San Luis Obispo CA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04879329
Phase2, Recruiting
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4
for
Congenital Myasthenic Syndrome
Location: Sacramento CA, O'Fallon IL, Chicago IL, Columbus OH,
Sponsor: argenx
Sex: All
Age: 2+
Code: NCT06078553
Recruiting
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements